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a b s t r a c t
Aim: To evaluate the performance of volumetric arc modulation with RapidArc against con-
ventional IMRT for head and neck cancers.
Background: RapidArc is a novel technique that has recently been made available for clin-
ical use. Planning study was done for volumetric arc modulation with RapidArc against
conventional IMRT for head and neck cancers.
Materials and methods: Ten patients with advanced tumors of the nasopharynx, oropharynx,
and hypopharynx were selected for the planning comparison study. PTV was delineated for
two different dose levels and planning was done by means of simultaneously integrated
boost technique. A total dose of 70Gy was delivered to the boost volume (PTV boost) and
57.7Gy to the elective PTV (PTV elective) in 35 equal treatment fractions. PTV boost consisted
of the gross tumor volumeand lymphnodes containing visiblemacroscopic tumor or biopsy-
proven positive lymph nodes, whereas the PTV elective consisted of elective nodal regions.
Planningwasdone for IMRTusing 9ﬁelds andRapidArcwith single arc, double arc. Beamwas
equally placed for IMRT plans. Single arc RapidArc plan utilizes full 360◦ gantry rotation and
double arc consists of 2 co-planar arcs of 360◦ in clockwise and counter clockwise direction.
Collimator was rotated from 35 to 45◦ to cover the entire tumor, which reduced the tongue
and groove effect during gantry rotation. All plans were generated with 6MV X-rays for
CLINAC 2100 Linear Accelerator. Calculations were done in the Eclipse treatment planning
system (version 8.6) using the AAA algorithm.
Results: Double arc plans show superior dose homogeneity in PTV compared to a single arc
and IMRT 9 ﬁeld technique. Target coverage was almost similar in all the techniques. The
sparing of spinal cord in terms of themaximum dose was better in the double arc technique
by 4.5% when compared to the IMRT 9 ﬁeld and single arc techniques. For healthy tissue,
no signiﬁcant changes were observed between the plans in terms of the mean dose and
integral dose. But RapidArc plans showed a reduction in the volume of the healthy tissue
irradiated at V15Gy (5.81% for single arc and 4.69% for double arc) and V20Gy (7.55% for singlearc and 5.89% for double arc) dose levels when compared to the 9-Field IMRT technique. For
brain stem,maximum dose was similar in all the techniques. The average MU (±SD) needed
to deliver the dose of 200 cGy per fraction was 474±80MU and 447±45MU for double arc
and single arc as against 948±162MU for the 9-Field IMRT plan. A considerable reduction
in maximum dose to the mandible by 6.05% was observed with double arc plan. Double arc
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shows a reduction in the parotid mean dose when compared with single arc and IMRT
plans. RapidArc using double arc provided a signiﬁcant sparing of OARs and healthy tissue
without compromising target coverage compared to IMRT. Themaindisadvantagewith IMRT
observed was higher monitor units and longer treatment time.
© 2012 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.
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h. Background
ead and neck cancer arises from mucous lining of respira-
ory, digestive tracts, salivary glands, and lymph nodes. Head
neck cancer is histologically heterogeneous and organs at
isk have less tolerance to radiation. Treatment planning for
dvanced head and neck cancer is a knotty problem due to
he complex shape of target volumes and the need to spare
ritical organs like the mandible, parotid glands, brainstem,
pinal cord, and normal structures. These organs often lie very
lose to the target volumes which commonly have an irreg-
lar concave shape. Due to the close proximity of tumor to
ritical structures, head and neck cancer presents a challenge
or radiotherapy. Treatment with radiotherapy is curative for
any patients with localized disease, but with current radi-
tion techniques, dose is limited by both acute and late side
ffects and the anatomy of the head and neck region which is
ery complex, with bony structures, soft tissues and air cavi-
ies. The lack of tumormotion due to breathingmakes patient
et up easy and can be reproduced accurately.
The transition of radiotherapy for head and neck cancer
rom 3D conformal radiotherapy (3D-CRT) to intensity mod-
lated radiation therapy (IMRT) made treatment of cancer
asier and beneﬁcial. The delivery of IMRT is accomplished
ith a set of ﬁxed radiation beams,which are shapedusing the
rojection of the target volume. In IMRT, treatment techniques
re better tailored to an individual patient’s situation based
n the extent and location of disease and normal anatomy.
MRT can sculpt precise dose distribution in three dimensions.
MRT presents more conformity for irregular target volumes
n the vicinity of critical organs and provides better tumor
ontrol and reduces dose to normal structures. The main dis-
dvantage of IMRT, in spite of its efﬁciency in dose conformity
o tumor, is increased treatment delivery time and increased
onitor units (MUs).
. Aim
o avoid the drawbacks offered by IMRT, a novel approach,
olumetric modulated radiation therapy (VMAT), has been
mplemented.1 RapidArc offers highly conformal dose distri-
ution, superior dosimetric accuracy, shrink in treatment time
nd enhanced sparing of critical structures. Recently, different
lanning studies have reported the efﬁciency of RapidArc over
2–5onventional IMRT. The aim of this study was to examine
hepotential clinical role of RapidArc (VarianMedical Systems,
alo Alto, CA) and compare them with conventional IMRT for
ead and neck cancers.z o.o. All rights reserved.
3. Materials and methods
Ten patients with advanced head and neck tumors (orophar-
ynx, hypopharynx, and nasopharynx) were selected for the
planning study. Plans were optimized with the aim to assess
organs at risk and healthy tissue sparing while enforcing
highly conformal target coverage. All patients underwent CT
simulation in a supine position with the neck hyper extended
using a head rest and custom aqua plastic masks. To reduce
the dose to the mandible and tongue, both were separated by
bite blocks, and to reduce dose to the shoulder it was brought
down by a pull board. CT images were taken at 3mm slice
thickness by means of a devoted CT scanner.
PTVwas delineated for two different dose levels (PTV boost
and PTV elective) and planningwas done bymeans of a simul-
taneously integrated boost technique (SIB technique). Studies
have been reported by Vosmik et al. for simultaneous inte-
grated boost and toxicity evaluation in IMRT for head and
neck cancers with and without concurrent chemotherapy.6 In
this study, PTV boost consisted of the gross tumor volume
and lymph nodes containing visible macroscopic tumor or
biopsy-proven positive lymph nodes, whereas the PTV elec-
tive consisted of elective nodal regions. The CTV was created
by manual contouring which included the GTV with a mar-
gin of 10mm for CTV and 3mm for PTV, respectively, which
involves microscopic spread and clinically uninvolved lymph
nodes and retrophargeal nodes. For PTV elective, a margin
of 3mm was prescribed to account for the set up errors.7,8
The organs at risk contoured were the brainstem, spinal cord,
parotid, and mandible. The healthy tissue was deﬁned as the
patient’s volume covered by the body volume excluding the
PTV.
3.1. Treatment planning objectives
A total dose of 70Gy was delivered to the boost volume (PTV
boost) and 57.7Gy to the elective PTV (PTV elective), in 35
equal treatment fractions. The planswere normalized to 100%
(70Gy) dose which covered the PTV. The DVH for the PTV,
parotid, spinal cord, mandible, and brain stem were calcu-
lated. For all plans (IMRT and RapidArc), planning objectives
were optimized to achieve the following parameters.
• For PTV, plans aimed to achieve the prescribed dose.
• Maximum doses to the spinal cord, mandible, and brainstem were tried to limit within 45Gy, 70Gy, 50Gy respec-
tively.
• Mean dose for both left & right parotid was aimed to restrict
below 26Gy.
d rad170 reports of practical oncology an
• A normalized total dose mean of 20Gy was associated with
a normal tissue complication rate of 13–14%, which was
deemed acceptable.
• For healthy tissue, various thresholds like V10, V15, and
V20 Gy were scored.
3.2. Conventional IMRT planning
Planning was generated for the IMRT 9 ﬁeld sliding window
technique. Beams were equally placed for all IMRT plans.
Nominal beamenergy of 6MVX-rayswas used. The IMRT opti-
mization engine computes optimal ﬂuence maps from dose
volume constraints derived from the general planning objec-
tive. Optimization was done by exploiting interaction window
with different objectives and priorities. Optimal ﬂuence maps
are then converted by a leaf motion calculator into actual ﬂu-
ence maps which are deliverable using a multi-leaf collimator
(MLC).
3.3. RapidArc planning
Two RapidArc plans were generated. RapidArc using single arc
and double arc. Single arc RapidArc plan utilized full gantry
rotation (gantry angles from 179 to 181◦) and the double arc
consisted of 2 co-planar arcswith the ﬁrst arc in clockwise and
the other arc in the counter clockwise direction (gantry angles
from 181 to 179 and 179 to 181◦, respectively). Collimator was
rotated from 35 to 45◦ depending on the plan, to cover the
entire tumor volume which reduced the tongue and groove
effect during gantry rotation.
All plans were generated with 6MV X-rays for CLINAC
2100 Linear accelerator for both IMRT and RapidArc. Opti-
mization and calculations were done in the Eclipse planning
system, version 8.6.15 (Varian Medical Systems, Palo Alto,
CA), using the anisotropic analytical algorithm (AAA).9,10 The
AAA is a 3D pencil beam convolution/superposition algo-
rithm that uses separate Monte Carlo derived modeling for
primary photons, scattered extra-focal photons and elec-
trons scattered from the beam limiting devices. The dose
deposition characteristics are modeled with six exponential
curves. The functional shapes of the fundamental physical
expressions in AAA enable analytical convolution, which sig-
niﬁcantly reduces the computational time. The AAA accounts
for the tissue heterogeneity anisotropically in the entire three-
dimensional neighborhood of an interaction site by using
photon scatter kernels in multiple lateral directions. This will
increase the accuracy of the scattered dose calculation. The
ﬁnal dose distribution is obtained by the superposition of the
dose calculated with photon and electron convolutions. The
grid size used for calculation is 2.5mm for both IMRT and Rap-
idArc. The dose objective was kept constantly the same as the
IMRT plans for the planning target volumes (PTV) and organ at
risk. The priority was changed to achieve the desired clinical
outcome. The “normal tissue objective” features in IMRT and
RA optimization were used to prevent the optimizer creating
hot spots in parts of the body outside the PTV. Couch param-
eters were included while planning so as to reduce errors due
to attenuation and scattering in both IMRT and RapidArc opti-
mization as well as in dose calculations.iotherapy 1 7 ( 2 0 1 2 ) 168–175
3.4. Parameters analyzed for planning
Dose volume histogram was used as a planning tool to esti-
mate plans. The coverage of PTV was calculated as the ratio
of target volume covered by 95% of isodose line divided by the
volume of PTV. For PTV, D98% and D2% values were reported
(dose received by 98% and 2% of the PTV volume) which rep-
resented the minimum and maximum doses.
Homogeneity index was evaluated as per ICRU 83, which
is expressed in terms of (D2% −D98%)/D50% (ratio of difference
between the dose covering 2% and 98% to the dose received by
50% of the PTV volume). The degree of conformity of the plans
wasmeasuredwith conformity index (CI). CI95% deﬁned as the
ratio between the patient volume receiving at least 95% of the
prescribed dose and the volume of the PTV. Total MUs and
the delivery time were accounted. Regarding the spinal cord,
maximum dose was scored. For the parotid, mean dose and
D50% were calculated. From healthy tissue, V10Gy, V15Gy and
V20Gy and the integral dose (equal to the mean dose times the
volume of healthy tissue), were scored. The paired, two-tails
Student’s t-testwas studied to evaluate thedifferencebetween
the techniques.
4. Results and discussion
Clinically acceptable IMRT and RapidArc plans were achieved
in all ten cases. PTV volumes for all the ten cases ranged from
294 cm3 to 510 cm.3 All the treatment plans were evaluated
using dose volume histogram (DVH). Tables 1A, 1B and 2g,
provide an overview of the numerical ﬁndings from aver-
age DVH analysis on PTV and OARs are reported as mean
values± standard deviation (SD) to assess the relative inter-
patient variability.
4.1. Planning target volume
Target coverage was almost similar in all the techniques. Dose
conformity was described in terms of the CI. RA using double
arc plans achieved the best conformity (CI95% =1.01±0.025)
while RA using single arc (CI95% =1.03±0.051) was slightly
inferior to RA with double arc but superior to IMRT
plan (CI95% =1.06±0.068). The in-homogeneity for PTV boost
was highest for single arc rapid plan with HI equal to
0.11127±0.008Gy and lowest for RA with double arc with
0.09554±0.011Gy and IMRT plan fell in between with HI
0.10793±0.027Gy. Also the homogeneity index for PTV elec-
tive was found to be 0.09453±0.010, 0.11459±0.014 and
0.08751±0.005 for IMRT, single arc RapidArc and double arc
RapidArc plans, respectively.
Fig. 1 shows the dose distribution of one of the patients
under study for the axial, sagittal, and coronal view of all the
techniques. Figs. 2 and 3 show the DVH for PTV and OARs
comparing the three plans for that particular patient.
The averageMU (±SD) needed to deliver the dose of 200 cGy
per fraction was 474±80MU and 447±45MU for double arc
and single arc as against 948±162MU for the 9-Field IMRT
plan. Calculated RapidArc “beamon” time (after patient setup)
was 150–180 s for RA with double arc and 70–90 s for RA with
single arc plans. Treatment times for a typical head and neck
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Table 1A – Dosimetric results for the PTV-boost.
Parameter IMRT Single arc RA plan Double arc RA plan P P* P**
D98% (Gy) 69.89 ± 0.19 69.15 ± 1.04 70.12 ± 1.04 0.298 0.645 0.349
D2% (Gy) 78.05 ± 2.44 77.41 ± 0.61 77.26 ± 1.56 0.693 0.293 0.901
HI 0.1079 ± 0.027 0.1113 ± 0.008 0.0955 ± 0.011 0.830 0.430 0.643
CI 95% 1.06 ± 0.068 1.03 ± 0.051 1.01 ± 0.03 0.278 0.032 0.643
MU 947.5 ± 162.42 447.25 ± 45.30 474.25 ± 80.47 0.004 0.002 0.434
P – paired t-test analysis: IMRT vs. single arc RA; P* – paired t-test analysis: IMRT vs. double arc RA; P** – paired t-test analysis: single arc RA vs.
double arc RA.
Table 1B – Dosimetric results for the PTV-elective.
Parameter IMRT Single arc RA plan Double arc RA plan P P* P**
D98% (Gy) 59.43 ± 1.147 57.98 ± 0.914 58.93 ± 1.46 0.182 0.079 0.376
D2% (Gy) 64.56 ± 1.868 65.10 ± 0.966 64.38 ± 1.606 0.526 0.699 0.431
HI 0.0945 ± 0.010 0.1146 ± 0.014 0.0875 ± 0.005 0.006 0.024 0.011
P – paired t-test analysis: IMRT vs. single arc RA; P* – paired t-test analysis: IMRT vs. double arc RA; P** – paired t-test analysis: single arc RA vs.
double arc RA.
Table 2 – Dosimetric results for the organ at risk and healthy tissue.
Organ Parameter IMRT Single arc RA plan Double arc RA plan P P* P**
Spinal cord Max. dose (Gy) 41.31 ± 2.65 40.78 ± 1.94 39.45 ± 1.94 0.054 0.011 0.030
Brain stem Max. dose 44.30 ± 9.82 46.74 ± 9.32 44.86 ± 8.67 0.159 0.046 0.060
L-parotid excluding PTV D mean (Gy) 20.28 ± 2.58 18.89 ± 2.39 18.86 ± 2.90 0.046 0.028 0.094
R-parotid excluding PTV D mean (Gy) 20.24 ± 2.35 18.29 ± 1.81 15.95 ± 5.68 0.031 0.025 0.044
Mandible Max. dose (Gy) 68.20 ± 4.03 65.15 ± 2.13 64.07 ± 2.44 0.140 0.017 0.386
Healthy tissue D mean (Gy) 8.14 ± 1.24 8.21 ± 1.29 8.32 ± 1.28 0.376 0.376 0.531
V10Gy(%) 22.92 ± 3.341 23.48 ± 3.43 23.74 ± 3.30 0.257 0.280 0.385
V15Gy(%) 20.47 ± 2.91 19.28 ± 2.78 19.51 ± 2.47 0.071 0.237 0.439
V20Gy(%) 17.02 ± 2.44 15.73 ± 2.83 16.01 ± 2.43 0.008 0.042 0.524
Int. dose (×104 Gy cm3) 7.12 ± 1.43 7.18 ± 1.50 7.26 ± 1.32 0.362 0.272 0.625
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double arc RA.
ancer treatment (2Gy) with nine ﬁelds IMRT with a dose rate
f 300MU/min were in the range between 15 and 20min.
.2. Spinal cord
ll plans respected the planning objective of 45Gy as maxi-
um dose to the spinal cord. The sparing of the spinal cord
n terms of the maximum dose was better in the double arc
echnique by 4.5% when compared to IMRT and single arc
echniques.
.3. Mandible
ll plans were able to achieve the objective of the mandible
xcluding PTV less than 70Gy asmaximumdose andRapidArc
sing double arc proved to be better in terms of sparing. A
onsiderable reduction in maximum dose to the mandible by
.05%was observed with double arc and 4.47%with single arc,
espectively when compared to the IMRT technique. Mandible
s not given high priority because of its late effect toxicity..4. Brain stem
o signiﬁcant difference was observed between the plans
n terms of maximum dose. But maximum dose to brain: IMRT vs double arc RA; P** – paired t-test analysis: single arc RA vs
stem was could be reduced well below 55Gy. IMRT technique
allowed enhanced sparing of the brain stem in terms of max-
imum dose of 44.30Gy when compared to RapidArc using
double arc with 44.74Gy and single arc with 44.86Gy, respec-
tively. Priority in the optimization window for the brain stem
was also kept lowbecause of its late effects to irradiation.With
the brain stem being a serial organ, maximum dose will be
considered.
4.5. Parotid
The analysis was carried out for left and right parotids sep-
arately. Larger sparing was observed for the contra-lateral
glands with all the techniques. Mean doses to the whole
parotids could be to keep within 26Gy for all the plans. The
mean dose to the left parotid excluding PTV was reduced
from 20.28Gy (IMRT) to 18.89Gy (single arc) and 18.86Gy (dou-
ble arc). The mean dose to the right parotid gland excluding
PTV ranged from 20.24Gy (IMRT) to 18.29Gy (single arc) and
15.95Gy (double arc). As the results suggest that thedosedeliv-
ered to 1/3 or 2/3 of the gland volumes, RA using single arc and
RA using double arc resulted in better sparing compared to
IMRT with a more prominent efﬁciency with double arc com-
pared to single arc. Also, mean doses to the parotid should
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al, sFig. 1 – Dose distribution for one patient under study for axi
be highly condensed to avoid xerostomia which needs more
attention in head and neck cases.11
4.6. Healthy tissue
RapidArc and IMRT plans presented similar dose volume his-
togram shapes for healthy tissue and no signiﬁcant changes
were observed between the plans in terms of the mean dose
and integral dose. The integral dose was computed as the
mean times the volume of healthy tissue irradiated. But Rapi-
dArc plans showed a reduction in the volume of healthy tissue
irradiated above V15Gy by 5.81% and 4.69% for single and dou-
ble arc, respectively. Similarly, forV20Gy, reduction by 7.55% for
single arc and 5.89% for double was observed.
Radiotherapy plays a vital role in the management of
locally advanced head and neck cancer. The present planningagittal and coronal views. (a) IMRT, (b) RA SA and (c) RA DA.
study intends to scrutinize the potential clinical role of Rapi-
dArc in head and neck cancer. The main reason for selecting
head and neck cases was that IMRT plans for head and neck
cases are demanding and require a strong dose modulation
because of large and irregular PTVs and more organs at risk.
IMRT for head and neck cancer has been investigated both in
planning and clinical levels. Studies on treatment outcome
and major toxicity were published by Gregoire et al.,12 Lee
et al.13 and Popovtzer and Eisbruch14 Also, a study related to
late radiation toxicity in patients after radiotherapy for head
and neck cancer was published by Golen et al.15
Different planning studies comparing the volumetric arc
modulation technique with conventional IMRT in different
sites have been published recently.2–5 The study published by
Palma et al. shows RapidArc progenitor on prostate showing
that variable dose rate volumetric arc modulation is beneﬁcial
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Fig. 2 – DVH for PTV for 1 case.
Fig. 3 – DVH for OAR’s for 1 case.
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s2ompared to IMRT with constant dose rate. Cozzi et al. and
ogliata et al.16 appraised the behavior of RapidArc on cervix
teri cancer and on small benign brain tumors. In all those
tudies RapidArc proved to be at least equivalent to IMRT interms of target coveragewhile showed beneﬁt in organs at risk
sparing.
When compared to IMRT, RapidArc using double arc proved
to have superior dose homogeneity in PTV. Also, RapidArc
d rad
r
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1
1
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plan showed improvements in organs at risk and healthy tis-
sue sparing without compromising target coverage. Unlike in
IMRT, optimization can be paused at each resolution level in
RapidArc, which will ensure additional time for the optimiza-
tion to attain saturation. This shows slight improvement in the
ﬁnal dose distribution. The main disadvantage of IMRT is the
higher number of MUs and resulting longer treatment time.
Such prolonged treatment fraction delivery times (greater
than 15min.) may have signiﬁcant impact on IMRT treatment
outcome, especially for tumorswith a low ˛/ˇ ratio and a short
repair halftime.17 Also, the analysis performed by Cozzi et al.
leads to the conclusion that RapidArc can reduce the periph-
eral dose from about 8% at 5 cm to about 30% at 15 cm from
the PTV surface.
RapidArc treatment is delivered rapidly, which has the
advantage of decreasing the risk of intra-fractional positional
shifts of the patient.18 It was found that no dosimetric beneﬁts
for the target volumewere notedwith RA over IMRT treatment
planning in terms of the CI. But when compared to IMRT Rap-
idArc plans using double arc show a better homogeneity and,
at the same time, presented amajor reduction of irradiation to
organs at risk. Even though the spinal cord dose is within the
tolerance limits with IMRT, it spares less than RA plan. Rapi-
dArc requires only 40% of the number of MUs compared with
the nine ﬁeld sliding window IMRT techniques. RA plans were
the fastest treatment option of modulated approaches in this
comparison.
Dose to healthy organs not in the proximity of the PTV
arises largely from collimator transmission and scatter radi-
ation from the LINAC, and this dose is proportional to the
number of MUs.19 Such scattered doses can increase the risk
of secondary tumors.20 Such a risk is now largely reduced by
the use of RapidArc without concessions to the dose distribu-
tion. Among RA plans, double arc RA plan, which involves two
full gantry rotations, offers a greater freedom in dose modula-
tion. The sum of two arcs reduces hot spots in the PTV where
the second arc compensates for areas of suboptimal dose.
A second possible explanation for the advantage of using two
arcs is a physical limit to dose homogeneity for a single arc
arising from limited leaf speed and the limited number of con-
trol points. Also, a second arc adds more freedom for possible
leaf positions. Each RapidArc plan required only a single opti-
mization session and the same number of optimization steps,
independent of the amount of interactive change of the opti-
mization objectives. It is obvious that sliding window IMRT
can be planned in a much shorter period of time as compared
to RapidArc, but RapidArc has the lowest estimated treatment
delivery time. Also with respect to plan quality, RapidArc can
meet the most dose–volume criteria.
5. Conclusion
The investigation for head and neck cancer using double arc
RapidArc proved a signiﬁcant sparing of OARs and healthy tis-
sue without compromising target coverage compared to IMRT.
The physical dose distribution was combined with a shorter
delivery time,which canhavean impact on thebiological level.
IMRT techniques result in higher monitor units and longer
1iotherapy 1 7 ( 2 0 1 2 ) 168–175
treatment time. RapidArc is a better treatment option in our
comparison for head and neck cancers.
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